Novel noncompetitive IL-1 receptor-biased ligand prevents infection- and inflammation-induced preterm birth

Journal of Immunology

Volumn 195, Issue 7, 2015, Pages 3402-3415

  Nadeau Vallée, Mathieu ^a,b   Quiniou, Christiane ^a   Palacios, Julia ^a   Hou, Xin ^a   Erfani, Atefeh ^a   Madaan, Ankush ^a,c   Sanchez, Mélanie ^a,c   Leimert, Kelycia ^d,e   Boudreault, Amarilys ^a   Duhamel, François ^a,b   Rivera, José Carlos ^a,f   Zhu, Tang ^a   Noueihed, Baraa ^a   Robertson, Sarah A ^g   Ni, Xin ^h   Olson, David M ^d,e   Lubell, William ^b   Girard, Sylvie ^a   Chemtob, Sylvain ^a,f  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^g UNIVERSITY OF ADELAIDE   (Australia)

^h SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; LIGAND; PROTEIN KINASE; RHO ASSOCIATED COILED COIL CONTAINING PROTEIN KINASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RNA; RYTVELA; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; 101.10 PEPTIDE; IL1B PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDE; RHO KINASE; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; INFECTION; INFLAMMATION; LEUKOCYTE; MOUSE; MYOMETRIUM; NONHUMAN; PLACENTA; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UTERUS CONTRACTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; IMMUNOLOGY; METABOLISM; PREGNANCY; PREMATURE BIRTH; UTERUS;

ANIMALS; CELL LINE; FEMALE; INFLAMMATION; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MYOMETRIUM; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES; PREGNANCY; PREMATURE BIRTH; RECEPTORS, INTERLEUKIN-1; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; UTERUS;

EID: 84942446686     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500758     Document Type: Article

References (78)

1. Hamilton, B. E., D. L. Hoyert, J. A. Martin, D. M. Strobino, and B. Guyer. 2013. Annual summary of vital statistics: 2010-2011. Pediatrics 131: 548-558.
2. Liu, L., H. L. Johnson, S. Cousens, J. Perin, S. Scott, J. E. Lawn, I. Rudan, H. Campbell, R. Cibulskis, M. Li, et al; Child Health Epidemiology Reference Group of WHO and UNICEF. 2012. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379: 2151-2161.
3. Romero, R., J. Espinoza, L. F. Goncalves, J. P. Kusanovic, L. A. Friel, and J. K. Nien. 2006. Inflammation in preterm and term labour and delivery. Semin. Fetal Neonatal Med. 11: 317-326.
4. MacIntyre, D. A., L. Sykes, T. G. Teoh, and P. R. Bennett. 2012. Prevention of preterm labour via the modulation of inflammatory pathways. J. Matern. Fetal Neonatal Med. 25(Suppl. 1): 17-20.
5. Liong, S., M. K. Di Quinzio, G. Fleming, M. Permezel, G. E. Rice, and H. M. Georgiou. 2013. Prediction of spontaneous preterm labour in at-risk pregnant women. Reproduction 146: 335-345.
6. Lyon, D., C. Y. Cheng, L. Howland, D. Rattican, N. Jallo, R. Pickler, L. Brown, and J. McGrath. 2010. Integrated review of cytokines in maternal, cord, and newborn blood: part I-associations with preterm birth. Biol. Res. Nurs. 11: 371-376.
7. Romero, R., M. Mazor, and B. Tartakovsky. 1991. Systemic administration of interleukin-1 induces preterm parturition in mice. Am. J. Obstet. Gynecol. 165: 969-971.
8. Romero, R., and B. Tartakovsky. 1992. The natural interleukin-1 receptor antagonist prevents interleukin-1-induced preterm delivery in mice. Am. J. Obstet. Gynecol. 167: 1041-1045.
9. Sadowsky, D. W., K. M. Adams, M. G. Gravett, S. S. Witkin, and M. J. Novy. 2006. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am. J. Obstet. Gynecol. 195: 1578-1589.
10. Skogstrand, K., D. M. Hougaard, D. E. Schendel, N. P. Bent, C. Svaerke, and P. Thorsen. 2008. Association of preterm birth with sustained postnatal inflammatory response. Obstet. Gynecol. 111: 1118-1128.
11. Genc, M. R., S. Gerber, M. Nesin, and S. S. Witkin. 2002. Polymorphism in the interleukin-1 gene complex and spontaneous preterm delivery. Am. J. Obstet. Gynecol. 187: 157-163.
12. Zaragoza, D. B., R. R. Wilson, B. F. Mitchell, and D. M. Olson. 2006. The interleukin 1beta-induced expression of human prostaglandin F2alpha receptor messenger RNA in human myometrial-derived ULTR cells requires the transcription factor, NFkappaB. Biol. Reprod. 75: 697-704.
13. Xu, C., A. Long, X. Fang, S. L. Wood, D. M. Slater, X. Ni, and D. M. Olson. 2013. Effects of PGF2a on the expression of uterine activation proteins in pregnant human myometrial cells from upper and lower segment. J. Clin. Endocrinol. Metab. 98: 2975-2983.
14. Bennett, P. 2012. Preterm labour. In Dewhurst's Textbook of Obstetrics & Gynaecology. D. K. Edmonds, ed. Wiley-Blackwell, Oxford, UK, p. 338-355.
15. Olson, D. M., I. Christiaens, S. Gracie, Y. Yamamoto, and B. F. Mitchell. 2008. Emerging tocolytics: challenges in designing and testing drugs to delay preterm delivery and prolong pregnancy. Expert Opin. Emerg. Drugs 13: 695-707.
16. Yoshimura, K., and E. Hirsch. 2005. Effect of stimulation and antagonism of interleukin-1 signaling on preterm delivery in mice. J. Soc. Gynecol. Investig. 12: 533-538.
17. Leitner, K., M. Al Shammary, M. McLane, M. V. Johnston, M. A. Elovitz, and I. Burd. 2014. IL-1 receptor blockade prevents fetal cortical brain injury but not preterm birth in a mouse model of inflammation-induced preterm birth and perinatal brain injury. Am. J. Reprod. Immunol. 71: 418-426.
18. Fidel, P. L., Jr., R. Romero, J. Cutright, N. Wolf, R. Gomez, H. Araneda, M. Ramirez, and B. H. Yoon. 1997. Treatment with the interleukin-I receptor antagonist and soluble tumor necrosis factor receptor Fc fusion protein does not prevent endotoxin-induced preterm parturition in mice. J. Soc. Gynecol. Investig. 4: 22-26.
19. Arend, W. P. 1993. Interleukin-1 receptor antagonist. Adv. Immunol. 54: 167-227.
20. Dinarello, C. A., and J. W. van der Meer. 2013. Treating inflammation by blocking interleukin-1 in humans. Semin. Immunol. 25: 469-484.
21. Keelan, J. A., S. Khan, F. Yosaatmadja, and M. D. Mitchell. 2009. Prevention of inflammatory activation of human gestational membranes in an ex vivo model using a pharmacological NF-kappaB inhibitor. J. Immunol. 183: 5270-5278.
22. Cookson, V. J., and N. R. Chapman. 2010. NF-kappaB function in the human myometrium during pregnancy and parturition. Histol. Histopathol. 25: 945-956.
23. Urban, J. D., W. P. Clarke, M. von Zastrow, D. E. Nichols, B. Kobilka, H. Weinstein, J. A. Javitch, B. L. Roth, A. Christopoulos, P. M. Sexton, et al. 2007. Functional selectivity and classical concepts of quantitative pharmacology. J. Pharmacol. Exp. Ther. 320: 1-13.
24. Quiniou, C., P. Sapieha, I. Lahaie, X. Hou, S. Brault, M. Beauchamp, M. Leduc, L. Rihakova, J. S. Joyal, S. Nadeau, et al. 2008. Development of a novel noncompetitive antagonist of IL-1 receptor. J. Immunol. 180: 6977-6987.
25. Rivera, J. C., N. Sitaras, B. Noueihed, D. Hamel, A. Madaan, T. Zhou, J. C. Honoré, C. Quiniou, J. S. Joyal, P. Hardy, et al. 2013. Microglia and interleukin-1b in ischemic retinopathy elicit microvascular degeneration through neuronal semaphorin-3A. Arterioscler. Thromb. Vasc. Biol. 33: 1881-1891.
26. Kajikawa, S., N. Kaga, Y. Futamura, C. Kakinuma, and Y. Shibutani. 1998. Lipoteichoic acid induces preterm delivery in mice. J. Pharmacol. Toxicol. Methods 39: 147-154.
27. Kakinuma, C., C. Kuwayama, N. Kaga, Y. Futamura, Y. Katsuki, and Y. Shibutani. 1997. Trophoblastic apoptosis in mice with preterm delivery and its suppression by urinary trypsin inhibitor. Obstet. Gynecol. 90: 117-124.
28. Huang, C., W. Y. Ma, M. I. Dawson, M. Rincon, R. A. Flavell, and Z. Dong. 1997. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc. Natl. Acad. Sci. USA 94: 5826-5830.
29. Joshi, A. R., I. Bobylev, G. Zhang, K. A. Sheikh, and H. C. Lehmann. 2015. Inhibition of Rho-kinase differentially affects axon regeneration of peripheral motor and sensory nerves. Exp. Neurol. 263: 28-38.
30. Zhu, T., F. Sennlaub, M. H. Beauchamp, L. Fan, J. S. Joyal, D. Checchin, S. Nim, P. Lachapelle, M. Sirinyan, X. Hou, et al. 2006. Proangiogenic effects of protease-activated receptor 2 are tumor necrosis factor-alpha and consecutively Tie2 dependent. Arterioscler. Thromb. Vasc. Biol. 26: 744-750.
31. Shynlova, O. P., A. D. Oldenhof, M. Liu, L. Langille, and S. J. Lye. 2002. Regulation of c-fos expression by static stretch in rat myometrial smooth muscle cells. Am. J. Obstet. Gynecol. 186: 1358-1365.
32. Goupil, E., D. Tassy, C. Bourguet, C. Quiniou, V. Wisehart, D. Pétrin, C. Le Gouill, D. Devost, H. H. Zingg, M. Bouvier, et al. 2010. A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2alpha-mediated Rho/ROCK signaling pathway. J. Biol. Chem. 285: 25624-25636.
33. Hsi, E. D., and D. G. Remick. 1995. Monocytes are the major producers of interleukin-1 beta in an ex vivo model of local cytokine production. J. Interferon Cytokine Res. 15: 89-94.
34. Aaltonen, R., T. Heikkinen, K. Hakala, K. Laine, and A. Alanen. 2005. Transfer of proinflammatory cytokines across term placenta. Obstet. Gynecol. 106: 802-807.
35. Zaretsky, M. V., J. M. Alexander, W. Byrd, and R. E. Bawdon. 2004. Transfer of inflammatory cytokines across the placenta. Obstet. Gynecol. 103: 546-550.
36. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-kappaB. Genes Dev. 18: 2195-2224.
37. MacIntyre, D. A., Y. S. Lee, R. Migale, B. R. Herbert, S. N. Waddington, D. Peebles, H. Hagberg, M. R. Johnson, and P. R. Bennett. 2014. Activator protein 1 is a key terminal mediator of inflammation-induced preterm labor in mice. FASEB J. 28: 2358-2368.
38. Friel, A. M., M. Curley, N. Ravikumar, T. J. Smith, and J. J. Morrison. 2005. Rho A/Rho kinase mRNA and protein levels in human myometrium during pregnancy and labor. J. Soc. Gynecol. Investig. 12: 20-27.
39. Christiaens, I., D. B. Zaragoza, L. Guilbert, S. A. Robertson, B. F. Mitchell, and D. M. Olson. 2008. Inflammatory processes in preterm and term parturition. J. Reprod. Immunol. 79: 50-57.
40. Qiao, L., H. Zhang, J. Yu, R. Francisco, P. Dent, M. P. Ebert, C. Röcken, and G. Farrell. 2006. Constitutive activation of NF-kappaB in human hepatocellular carcinoma: evidence of a cytoprotective role. Hum. Gene Ther. 17: 280-290.
41. Mora, A. L., R. A. Corn, A. K. Stanic, S. Goenka, M. Aronica, S. Stanley, D. W. Ballard, S. Joyce, and M. Boothby. 2003. Antiapoptotic function of NF-kappaB in T lymphocytes is influenced by their differentiation status: roles of Fas, c-FLIP, and Bcl-xL. Cell Death Differ. 10: 1032-1044.
42. Ivanov, V. N., G. Deng, E. R. Podack, and T. R. Malek. 1995. Pleiotropic effects of Bcl-2 on transcription factors in T cells: potential role of NF-kappa B p50-p50 for the anti-apoptotic function of Bcl-2. Int. Immunol. 7: 1709-1720.
43. Romero, R., J. Espinoza, T. Chaiworapongsa, and K. Kalache. 2002. Infection and prematurity and the role of preventive strategies. Semin. Neonatol. 7: 259-274.
44. Lindström, T. M., and P. R. Bennett. 2005. The role of nuclear factor kappa B in human labour. Reproduction 130: 569-581.
45. Fang, X., S. Wong, and B. F. Mitchell. 2000. Effects of LPS and IL-6 on oxytocin receptor in non-pregnant and pregnant rat uterus. Am. J. Reprod. Immunol. 44: 65-72.
46. Lappas, M., and G. E. Rice. 2007. The role and regulation of the nuclear factor kappa B signalling pathway in human labour. Placenta 28: 543-556.
47. Romero, R., S. Durum, C. A. Dinarello, E. Oyarzun, J. C. Hobbins, and M. D. Mitchell. 1989. Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglandins 37: 13-22.
48. Alnaif, B., R. J. Benzie, and W. Gibb. 1994. Studies on the action of interleukin-1 on term human fetal membranes and decidua. Can. J. Physiol. Pharmacol. 72: 133-139.
49. Ammälä, M., T. Nyman, A. Salmi, and E. M. Rutanen. 1997. The interleukin-1 system in gestational tissues at term: effect of labour. Placenta 18: 717-723.
50. Romero, R., J. Miranda, P. Chaemsaithong, T. Chaiworapongsa, J. P. Kusanovic, Z. Dong, A. I. Ahmed, M. Shaman, K. Lannaman, B. H. Yoon, et al. 2014. Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes. J. Matern. Fetal Neonatal Med. 29: 1-16.
51. Greten, F. R., and M. Karin. 2004. The IKK/NF-kappaB activation pathway: a target for prevention and treatment of cancer. Cancer Lett. 206: 193-199.
52. Nørgard, B., L. Pedersen, L. A. Christensen, and H. T. Sørensen. 2007. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am. J. Gastroenterol. 102: 1406-1413.
53. Prusty, B. K., S. Hedau, A. Singh, P. Kar, and B. C. Das. 2007. Selective suppression of NF-kBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality. Mol. Med. 13: 518-526.
54. Lim, R., and M. Lappas. 2014. Differential expression of AP-1 proteins in human myometrium after spontaneous term labour onset. Eur. J. Obstet. Gynecol. Reprod. Biol. 177: 100-105.
55. Lappas, M., C. Riley, R. Lim, G. Barker, G. E. Rice, R. Menon, and M. Permezel. 2011. MAPK and AP-1 proteins are increased in term pre-labour fetal membranes overlying the cervix: regulation of enzymes involved in the degradation of fetal membranes. Placenta 32: 1016-1025.
56. Mitchell, J. A., and S. J. Lye. 2002. Differential expression of activator protein-1 transcription factors in pregnant rat myometrium. Biol. Reprod. 67: 240-246.
57. Wang, H., and Y. V. Stjernholm. 2007. Plasma membrane receptor mediated MAPK signaling pathways are activated in human uterine cervix at parturition. Reprod. Biol. Endocrinol. 5: 3.
58. Allport, V. C., D. M. Slater, R. Newton, and P. R. Bennett. 2000. NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol. Hum. Reprod. 6: 561-565.
59. Khanjani, S., V. Terzidou, M. R. Johnson, and P. R. Bennett. 2012. NFkB and AP-1 drive human myometrial IL8 expression. Mediators Inflamm. 2012: 504952.
60. Deng, X., M. Xu, C. Yuan, L. Yin, X. Chen, X. Zhou, G. Li, Y. Fu, C. A. Feghali-Bostwick, and L. Pang. 2013. Transcriptional regulation of increased CCL2 expression in pulmonary fibrosis involves nuclear factor-kB and activator protein-1. Int. J. Biochem. Cell Biol. 45: 1366-1376.
61. Inoue, T., T. Kimura, C. Azuma, J. Inazawa, M. Takemura, T. Kikuchi, Y. Kubota, K. Ogita, and F. Saji. 1994. Structural organization of the human oxytocin receptor gene. J. Biol. Chem. 269: 32451-32456.
62. Benbow, U., and C. E. Brinckerhoff. 1997. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15: 519-526.
63. Mitchell, J. A., and S. J. Lye. 2005. Differential activation of the connexin 43 promoter by dimers of activator protein-1 transcription factors in myometrial cells. Endocrinology 146: 2048-2054.
64. Geimonen, E., W. Jiang, M. Ali, G. I. Fishman, R. E. Garfield, and J. Andersen. 1996. Activation of protein kinase C in human uterine smooth muscle induces connexin-43 gene transcription through an AP-1 site in the promoter sequence. J. Biol. Chem. 271: 23667-23674.
65. Mitchell, J. A., and S. J. Lye. 2001. Regulation of connexin43 expression by c-fos and c-jun in myometrial cells. Cell Commun. Adhes. 8: 299-302.
66. Liu, H., R. W. Redline, and Y. W. Han. 2007. Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response. J. Immunol. 179: 2501-2508.
67. Kim, Y. M., R. Romero, T. Chaiworapongsa, G. J. Kim, M. R. Kim, H. Kuivaniemi, G. Tromp, J. Espinoza, E. Bujold, V. M. Abrahams, and G. Mor. 2004. Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am. J. Obstet. Gynecol. 191: 1346-1355.
68. Nitsche, J. F., S. W. Jiang, and B. C. Brost. 2010. Toll-like receptor-2 and Toll-like receptor-4 expression on maternal neutrophils during pregnancy. Am. J. Reprod. Immunol. 64: 427-434.
69. Patni, S., L. P. Wynen, A. L. Seager, G. Morgan, J. O. White, and C. A. Thornton. 2009. Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term. Biol. Reprod. 80: 243-248.
70. Noguchi, T., T. Sado, K. Naruse, H. Shigetomi, A. Onogi, S. Haruta, R. Kawaguchi, A. Nagai, Y. Tanase, S. Yoshida, et al. 2010. Evidence for activation of Toll-like receptor and receptor for advanced glycation end products in preterm birth. Mediators Inflamm. 2010: 490406.
71. Fortunato, S. J., R. Menon, K. F. Swan, and S. J. Lombardi. 1996. Interleukin-10 inhibition of interleukin-6 in human amniochorionic membrane: transcriptional regulation. Am. J. Obstet. Gynecol. 175: 1057-1065.
72. Lim, R., G. Barker, C. A. Wall, and M. Lappas. 2013. Dietary phytophenols curcumin, naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and myometrium. Mol. Hum. Reprod. 19: 451-462.
73. Lappas, M. 2013. Forkhead box O1 (FOXO1) in pregnant human myometrial cells: a role as a pro-inflammatory mediator in human parturition. J. Reprod. Immunol. 99: 24-32.
74. Fiedler, T., A. Salamon, S. Adam, N. Herzmann, J. Taubenheim, and K. Peters. 2013. Impact of bacteria and bacterial components on osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Exp. Cell Res. 319: 2883-2892.
75. Böcker, U., T.Manigold, J.M.Watson,M. V. Singer, and S. Rossol. 2001. Regulation of Staphylococcus aureus-mediated activation of interleukin-18 in peripheral blood mononuclear cells. Eur. Cytokine Netw. 12: 631-638.
76. Huang, L., A. M. Krieg, N. Eller, and D. E. Scott. 1999. Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heatinactivated bacteria. Infect. Immun. 67: 6257-6263.
77. Girard, S., L. Tremblay, M. Lepage, and G. Sébire. 2010. IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. J. Immunol. 184: 3997-4005.
78. Blencowe, H., S. Cousens, D. Chou, M. Oestergaard, L. Say, A. B. Moller, M. Kinney, and J. Lawn, Born Too Soon Preterm Birth Action Group. 2013. Born too soon: the global epidemiology of 15 million preterm births. Reprod. Health 10(Suppl. 1): S2.